跳至主要内容
临床试验/NCT02044055
NCT02044055已完成不适用

Hepatitis D Virus (HDV) Mother-To-Child Transmission (MTCT) From Hepatitis B Virus (HBV)-Hepatitis D Virus (HDV) Co-infected Pregnant Women: a Retrospective Study.

Hopital Lariboisière1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2014年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
54
试验地点
1
主要终点
Hepatitis D antibodies (Ab) in children

研究概览

简要总结

HBV can be transmitted from mother-to-child, with a risk increasing according to maternal HBV DNA during pregnancy. HDV is a defective virus using HBs Ag for its own replication. Nucleosides analogues have only a minor impact on quantitative HBs Ag level. Data about vertical HDV transmission are old, justifying a new study.

详细描述

Hepatitis B Virus (HBV) can be transmitted from mother-to-child, with a risk increasing according to maternal HBV DNA viral load during the last trimester of pregnancy. Nucleosides analogues, lamivudine, telbivudine, or nucleotides analogues, tenofovir DF decrease HBV mother-to-child transmission risk, and are recommended in Guidelines (EASL 2012) for pregnant women with HBV DNA above 1,000 000 I.U/mL. HDV is a defective virus using HBs Ag for its own replication. HDV-HBV co-infection is a re-emerging infectious disease in western countries, due to immigration of people coming from endemic areas. Nucleosides analogues have only a minor impact on quantitative HBs Ag level (Boyd A et al. AIDS Research and Human Retroviruses 2013). Data about vertical HDV transmission are old (Rizzetto, et al. J Med Virol 1982), before a large use of nucleosides/nucleotides analogues in HBV infected pregnant women, justifying a new study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
9 Months 至 15 Years(Child)
性别
All
接受健康志愿者

入选标准

  • children born in the Maternity Department, Lariboisiere Hospital,
  • from HBV-HDV co-infected women
  • with a positive HDV RNA during pregnancy in the pregnant woman

排除标准

  • negative HDV RNA during pregnancy in the pregnant woman

结局指标

主要结局

Hepatitis D antibodies (Ab) in children

时间窗: up to 10 years (expected average: 5 years)

Antibodies (Ab) against Hepatitis D Virus (HDV)

次要结局

  • HDV RNA in children with positive HDV Ab(up to 10 years (expected average: 5 years))

研究者

发起方
Hopital Lariboisière
申办方类型
Other
责任方
Principal Investigator
主要研究者

Célia Lloret-Linares, MD PhD

Professor at University Paris VII Denis Diderot, physician

Hopital Lariboisière

研究点 (1)

Loading locations...

相似试验